Related Experiment Videos
Auto-immune haemolytic anaemia in ulcerative colitis
1Department of Clinical Haematology, St. George Hospital, Kogarah, Sydney, Australia.
Acta Haematologica
|January 1, 1994
Summary
Auto-immune haemolytic anaemia (AIHA) in ulcerative colitis (UC) patients can present uniquely. Some cases are independent of UC activity, while most require active colitis control to manage haemolysis.
Area of Science:
- Hematology
- Gastroenterology
- Immunology
Background:
- Auto-immune haemolytic anaemia (AIHA) is a rare complication of ulcerative colitis (UC).
- Understanding the relationship between AIHA and UC activity is crucial for patient management.
Observation:
- Two novel cases of AIHA associated with UC are presented.
- The first case demonstrated complement-only red blood cell coating on direct antiglobulin testing.
- The second case achieved successful treatment with danazol.
Findings:
- This study reviews 40 cases of AIHA associated with UC.
- AIHA in UC patients appears to fall into two distinct groups: independent of UC activity (4/40) or dependent on active colitis (36/40).
- Effective management of AIHA in most UC patients hinges on controlling active colitis.
Implications:
- These findings highlight the heterogeneous nature of AIHA in UC.
- Identifying the specific subtype of AIHA may guide therapeutic strategies.
- Controlling active ulcerative colitis is paramount for managing associated auto-immune haemolytic anaemia.